2022
Proteomic characterization of post-mortem human brain tissue following ultracentrifugation-based subcellular fractionation
Kandigian SE, Ethier EC, Kitchen RR, Lam TT, Arnold SE, Carlyle BC. Proteomic characterization of post-mortem human brain tissue following ultracentrifugation-based subcellular fractionation. Brain Communications 2022, 4: fcac103. PMID: 35611312, PMCID: PMC9123841, DOI: 10.1093/braincomms/fcac103.Peer-Reviewed Original ResearchProteomic characterizationSubcellular fractionationTissue cell type compositionMultiple cellular organellesPost-mortem human brain tissueMajority of proteinsThousands of proteinsCell type compositionHuman brain tissueSame biological sampleSpatial proteomicsProtein functionProtein localizationOrganellar markersCellular organellesCellular localizationDrug targetsSubcellular levelOrganellesAbundant organellesCentrifugation fractionsProteinCell linesDisease mechanismsMembrane breakdown
2018
Evaluation of the Phosphoproteome of Mouse Alpha 4/Beta 2-Containing Nicotinic Acetylcholine Receptors In Vitro and In Vivo
Miller MB, Wilson RS, Lam TT, Nairn AC, Picciotto MR. Evaluation of the Phosphoproteome of Mouse Alpha 4/Beta 2-Containing Nicotinic Acetylcholine Receptors In Vitro and In Vivo. Proteomes 2018, 6: 42. PMID: 30326594, PMCID: PMC6313896, DOI: 10.3390/proteomes6040042.Peer-Reviewed Original ResearchProtein kinase APhosphorylation sitesPKA sitesHEK cellsNicotinic acetylcholine receptorsCalmodulin-dependent protein kinase IICalcium/calmodulin-dependent protein kinase IIProtein kinase IIAcetylcholine receptorsKinase AKinase IIMouse brainSubunit phosphorylationNovel siteSubunitsAcute nicotine administrationΒ2 subunitMammalian brainCaMKIIPhosphorylationReceptor functionΑ4 subunitHuman brain tissueBeta 2Nicotine administration